ACADIA Pharmaceuticals Inc (ACAD)
Quick ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 319,589 | 188,657 | 114,846 | 147,435 | 326,028 |
| Short-term investments | US$ in thousands | 436,404 | 250,208 | 301,977 | 373,271 | 305,930 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 394,870 | 254,254 | 125,630 | 96,068 | 105,967 |
| Quick ratio | 1.91 | 1.73 | 3.32 | 5.42 | 5.96 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($319,589K
+ $436,404K
+ $—K)
÷ $394,870K
= 1.91
The quick ratio of ACADIA Pharmaceuticals Inc has exhibited a downward trend over the years, declining from 5.96 on December 31, 2020, to 1.91 on December 31, 2024. This indicates a reduction in the company's ability to meet its short-term liabilities with its most liquid assets. While the quick ratio still remains above 1, suggesting that the company can cover its current liabilities with its quick assets, the decreasing trend may raise concerns about ACADIA Pharmaceuticals Inc's liquidity position. Further monitoring of the quick ratio is warranted to assess the company's ability to manage its short-term financial obligations effectively.
Peer comparison
Dec 31, 2024